Clinical Trial Update: Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of telitacicept as maintenance treatment for ANCA-associated vasculitis in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: ANCA-associated Vasculitis, Maintenance Therapy | Phase 4 | Status: RECRUITING